Introduction: Developing a biosimilar monoclonal antibody involves far more than demonstrating analytical similarity with the reference product. One of the … Continue reading Case Study: Forced Degradation and Stress Testing to Predict Stability Risks in a Bevacizumab Biosimilar Programme